EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Long-Term Outcomes of Patients Requiring Pacemaker Implantation After Transcatheter Aortic Valve Replacement

Patrick Badertscher, Stefan Stortecky, Teodor Serban, Sven Knecht, Dik Heg, David Tueller, Raban Jeger, Oliver Reuthebuch, Olivier Muller, Stefan Toggweiler, Peter Wenaweser, Christoph Huber und 8 weitere

JACC: Cardiovascular Interventions · 2025-05 · 18 (9) · 1163-1171

DOI: 10.1016/j.jcin.2025.03.028 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-05. Verfasst von Patrick Badertscher und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital Basel, Basel, Switzerland; Cardiovascular Research Institute Basel, University Hospital Basel, Basel, S…. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Pacemaker, Artificial, Cardiac Pacing, Artificial, Aortic Valve Stenosis. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The impact of pacemaker (PM) implantation on outcomes following transcatheter aortic valve replacement (TAVR) remains controversial, especially as TAVR indications expand to low-risk patients. OBJECTIVES: This study sought to evaluate the all-cause and cardiovascular mortality of patients undergoing PM implantation after TAVR. METHODS: In this prospective, observational, nationwide TAVR cohort study, the outcomes of patients undergoing permanent PM implantation were investigated. Patients were enrolled from 19 centers across Switzerland between February 2011 and June 2022. RESULTS: Among 13,360 patients enrolled (mean age 82 ± 7 years, 47% female, self-expanding valves 48%, median follow-up 889 days [Q1-Q3: 365-1,765 days]), 2,028 (15%) required PM implantation within 30 days post-TAVR. Patients requiring post-TAVR PM implantation were older (82 ± 6 years of age vs 81 ± 7 years of age), were predominantly male (58% vs 50%), and more often had atrial fibrillation (34% vs 29%). At 1-year follow-up, these patients had higher overall mortality (aHR: 1.15; 95% CI: 1.05-1.26; P = 0.002) and cardiovascular mortality (aHR: 1.25; 95% CI: 1.06-1.46; P = 0.006). These trends persisted at 5- and 10-year follow-up. After multivariable adjustments, significantly higher rates of cardiovascular mortality, LVEF decline ≥10%, and NYHA functional class III or IV at 1-year follow-up were observed (aHR: 1.44,; 95% CI: 1.35-1.54; P < 0.001), along with higher all-cause and cardiovascular mortality rates at 5- and 10-year follow-up in patients requiring PM implantation following TAVR compared with those not needing a PM. CONCLUSIONS: In this large nationwide registry, patients receiving PM implantation within 30 days after TAVR had significantly higher rates of overall and cardiovascular mortality up to 10 years. (SwissTAVI Registry; NCT01368250).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementPacemaker, ArtificialCardiac Pacing, ArtificialAortic Valve StenosisArrhythmias, CardiacAortic ValveHumansFemaleMaleAged, 80 and overRegistriesTime FactorsTreatment OutcomeProspective StudiesAgedRisk FactorsRisk AssessmentSwitzerland

Stichwörter der Autor:innen

cardiovascular mortalityheart failurehigh-degree atrioventricular blockpacemaker implantationtranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiology, University Hospital Basel, Basel, Switzerland; Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland. Electronic address: patrick.badertscher@usb.ch.
  • Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
  • Department of Cardiology, University Hospital Basel, Basel, Switzerland; Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland.
  • CTU Bern, University of Bern, Bern, Switzerland.
  • Department of Cardiology, Triemli Hospital Zurich, Zurich, Switzerland.
  • Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland; Department of Cardiology, Triemli Hospital Zurich, Zurich, Switzerland.

Zitieren

APA

Badertscher, P., Stortecky, S., Serban, T., Knecht, S., Heg, D., Tueller, D., Jeger, R., Reuthebuch, O., Muller, O., Toggweiler, S., Wenaweser, P., Huber, C., Roffi, M., Ferrari, E., Reichlin, T., Nestelberger, T., Mahfoud, F., Kühne, M., Sticherling, C., & SwissTAVI Investigators (2025). Long-Term Outcomes of Patients Requiring Pacemaker Implantation After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions, 18(9), 1163-1171. https://doi.org/10.1016/j.jcin.2025.03.028

Vancouver

Badertscher P, Stortecky S, Serban T, Knecht S, Heg D, Tueller D, et al. Long-Term Outcomes of Patients Requiring Pacemaker Implantation After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 2025;18(9):1163-1171. doi:10.1016/j.jcin.2025.03.028

BibTeX
@article{Badertscher2025,
  author = {Badertscher, Patrick and Stortecky, Stefan and Serban, Teodor and Knecht, Sven and Heg, Dik and Tueller, David and Jeger, Raban and Reuthebuch, Oliver and Muller, Olivier and Toggweiler, Stefan and Wenaweser, Peter and Huber, Christoph and Roffi, Marco and Ferrari, Enrico and Reichlin, Tobias and Nestelberger, Thomas and Mahfoud, Felix and Kühne, Michael and Sticherling, Christian and SwissTAVI Investigators, SwissTAVI Investigators},
  title = {Long-Term Outcomes of Patients Requiring Pacemaker Implantation After Transcatheter Aortic Valve Replacement},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {9},
  pages = {1163--1171},
  doi = {10.1016/j.jcin.2025.03.028}
}
Kostenlos starten →